scholarly journals Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study

2017 ◽  
Vol Volume 7 ◽  
pp. 79-93 ◽  
Author(s):  
Babita Bisht ◽  
Warren Darling ◽  
Emily White ◽  
Kaitlin White ◽  
E. Torage Shivapour ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Pilot Study ◽  
Progressive Multiple Sclerosis ◽  
Multimodal Intervention ◽  
Prospective Longitudinal

scholarly journals High doses of biotin in chronic progressive multiple sclerosis: A pilot study

2015 ◽  
Vol 4 (2) ◽  
pp. 159-169 ◽  
Author(s):  
Frédéric Sedel ◽  
Caroline Papeix ◽  
Agnès Bellanger ◽  
Valérie Touitou ◽  
Christine Lebrun-Frenay ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Pilot Study ◽  
Progressive Multiple Sclerosis ◽  
Chronic Progressive Multiple Sclerosis ◽  
High Doses

scholarly journals Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

BMC Neurology ◽  
2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Patrick Vermersch ◽  
Rabah Benrabah ◽  
Nicolas Schmidt ◽  
Hélène Zéphir ◽  
Pierre Clavelou ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Pilot Study ◽  
Progressive Multiple Sclerosis

Overview of London trial of intramuscular interferon-b1a in primary-progressive multiple sclerosis

2004 ◽  
Vol 10 (3_suppl) ◽  
pp. S56-S57 ◽  
Author(s):  
David H Miller ◽  
Siobhan M Leary ◽  
Alan J Thompson
Keyword(s):  
Multiple Sclerosis ◽  
Pilot Study ◽  
Progressive Multiple Sclerosis ◽  
Primary Progressive Multiple Sclerosis ◽  
Primary Progressive ◽  
Patient Cohort ◽  
Quantitative Mr ◽  
Double Blinded ◽  
Clinical Measures ◽  
The Relationship

This short monograph describes the rationale, design and outcome of a pilot study of beta interferon in patients with primary progressive MS. A total of 50 patients were studied for 2 years using a randomized, double-blinded, placebo -controlled design. There was an emphasis on using MRI measures to evaluate outcome. The study showed that with the numbers studied, useful data could be obtained on safety and on efficacy on certain MRI measures. A larger study would be required to evaluate treatment on disability in this patient cohort and further work is needed to elucidate the relationship between quantitative MR and clinical measures over the longer term.

Sign in / Sign up

Export Citation Format

Share Document